KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | 0.0% | 5,900 | +1.4% | 0.00% | – |
| Q2 2022 | $2,000 | -88.9% | 5,816 | -56.0% | 0.00% | – |
| Q1 2022 | $18,000 | -47.1% | 13,210 | -53.7% | 0.00% | – |
| Q4 2021 | $34,000 | +1033.3% | 28,507 | +2750.7% | 0.00% | – |
| Q3 2021 | $3,000 | -40.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -90.0% | 1,000 | -86.6% | 0.00% | – |
| Q1 2021 | $50,000 | -90.3% | 7,440 | -90.2% | 0.00% | – |
| Q4 2020 | $516,000 | -16.8% | 76,156 | -7.8% | 0.00% | – |
| Q3 2020 | $620,000 | -44.9% | 82,616 | -22.9% | 0.00% | – |
| Q2 2020 | $1,126,000 | +599.4% | 107,172 | +486.3% | 0.00% | – |
| Q1 2020 | $161,000 | +0.6% | 18,280 | -57.8% | 0.00% | – |
| Q4 2019 | $160,000 | -19.6% | 43,302 | -17.0% | 0.00% | – |
| Q3 2019 | $199,000 | +148.8% | 52,158 | +311.6% | 0.00% | – |
| Q2 2019 | $80,000 | -36.5% | 12,673 | -17.1% | 0.00% | – |
| Q1 2019 | $126,000 | +29.9% | 15,290 | -23.0% | 0.00% | – |
| Q4 2018 | $97,000 | -97.6% | 19,856 | -95.1% | 0.00% | -100.0% |
| Q3 2018 | $3,960,000 | -29.8% | 401,223 | -2.3% | 0.00% | -50.0% |
| Q2 2018 | $5,638,000 | -2.0% | 410,585 | +13.0% | 0.00% | 0.0% |
| Q1 2018 | $5,751,000 | +8.5% | 363,289 | +26.7% | 0.00% | 0.0% |
| Q4 2017 | $5,301,000 | +41.3% | 286,694 | +74.5% | 0.00% | +100.0% |
| Q3 2017 | $3,752,000 | – | 164,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |